Signet Laboratories, Inc. Announces Availability Of Two New Monoclonal Antibodies, L1 And PTEN
6/13/2006 12:04:23 PM
More...
|
Covance Inc. (CVD) Expands Its Antibody Products And Services With The Acquisition Of Signet Laboratories, Inc. For $8.95 Million
6/1/2006 10:54:21 AM
More...
|
Signet Laboratories, Inc. Announces Availability Of Seven New Monoclonal CEACAM Antibodies
5/24/2006 11:56:49 AM
More...
|
Signet Laboratories, Inc. Announces The Release Of An sAPPbeta Antibody Critical For Alzheimer's Disease Research
4/26/2006 10:27:43 AM
More...
|
Signet Laboratories, Inc. Announces Availability Of Two New Monoclonal Antibodies
3/16/2006 11:05:31 AM
More...
|
Signet Laboratories, Inc. Announces License Agreement With Bayer Diagnostics For Urinary Trypsin Inhibitor Immunoassays To Further Research Inflammatory Disease
3/1/2006 10:57:31 AM
More...
|
Signet Laboratories, Inc. And AsymmetRx, Inc. Announce Exclusive Agreement For Distribution Of FDA 510(k) Cleared Diagnostic Tests ('Prostate-63') For The Diagnosis Of Prostate Cancer Using p63
2/21/2006 10:25:13 AM
More...
|
Signet Laboratories, Inc. Announces 2006 Conference Schedule
1/31/2006 12:25:58 PM
More...
|
Signet Laboratories, Inc. Announces Availability Of Monoclonal Cyclin E
1/24/2006 12:33:12 PM
More...
|
Signet Laboratories, Inc. Announces Availability Of Three New Monoclonal Antibodies
12/9/2005 9:10:53 AM
More...
|
|